Related NQMC Measures

Related Measure Summaries:

• Prostate cancer: percentage of patients, regardless of age, with a diagnosis of clinically localized prostate cancer receiving external beam radiotherapy as primary therapy to the prostate with or without nodal irradiation (no metastases; no salvage therapy) who receive three-dimensional conformal radiotherapy (3D-CRT) or intensity modulated radiation therapy (IMRT). . American Urological Association - Medical Specialty Society; Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration.
• Prostate cancer: percentage of patients, regardless of age, with a diagnosis of clinically localized prostate cancer receiving interstitial prostate brachytherapy, OR external beam radiotherapy to the prostate, OR radical prostatectomy, OR cryotherapy who received counseling on, at a minimum, the following treatment options for clinically localized disease prior to initiation of treatment: active surveillance, AND interstitial prostate brachytherapy, AND external beam radiotherapy, AND radical prostatectomy. . American Urological Association - Medical Specialty Society; Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration.
• Prostate cancer: percentage of patients, regardless of age, with a diagnosis of prostate cancer at high risk of recurrence, receiving external beam radiotherapy to the prostate who were prescribed adjuvant hormonal therapy (GnRH agonist or antagonist). . American Urological Association - Medical Specialty Society; Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration.
• Prostate cancer: percentage of patients, regardless of age, with a diagnosis of prostate cancer receiving interstitial prostate brachytherapy, OR external beam radiotherapy to the prostate, OR radical prostatectomy, OR cryotherapy with documented evaluation of prostate-specific antigen (PSA), AND primary tumor (T) stage, AND Gleason score prior to initiation of treatment. . American Urological Association - Medical Specialty Society; Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration.
• Prostate cancer: percentage of patients, regardless of age, with a diagnosis of prostate cancer, at low risk of recurrence, receiving interstitial prostate brachytherapy, OR external beam radiotherapy to the prostate, OR radical prostatectomy, OR cryotherapy who did not have a bone scan performed at any time since diagnosis of prostate cancer. . American Urological Association - Medical Specialty Society; Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration.
• Prostate cancer: percentage of patients, regardless of age, with a new diagnosis of prostate cancer with documented evaluation of prostate-specific antigen (PSA), AND primary tumor (T) stage, AND Gleason score. . American Urological Association - Medical Specialty Society; Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration.